Good practice guidelines for the use of statistical regression models in economic evaluations

PharmacoEconomics

Volumn 31, Issue 8, 2013, Pages 643-652

  Kearns, Ben ^a   Ara, Roberta ^a   Wailoo, Allan ^a   Manca, Andrea ^b   Alava, Monica Hernández ^a   Abrams, Keith ^c   Campbell, Mike ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHECKLIST; COST EFFECTIVENESS ANALYSIS; DECISION ANALYTIC MODEL; DECISION MAKING; ECONOMIC EVALUATION; HUMAN; INFORMATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOM SAMPLE; REGRESSION ANALYSIS; SAMPLE SIZE; STANDARD; STATISTICAL MODEL; SYSTEMATIC REVIEW; UNCERTAINTY;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HUMANS; MODELS, ECONOMIC; PRACTICE GUIDELINES AS TOPIC; REGRESSION ANALYSIS;

EID: 84881122165     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.1007/s40273-013-0069-y     Document Type: Article

References (27)

1. National Institute for Health and Clinical Excellence. Published technology appraisals. http://www.nice.org.uk/Guidance/TA/Published. 16 Oct 2012.
2. Kearns B, Ara R, Waillo A. NICE Decision Support Unit: regression methods. http://www.nicedsu.org.uk/Regression-methods(2391678).htm. 1-8-2013.
3. Cox DR, Snell EJ. Applied statistics: principles and examples. London: Chapman & Hall; 1981.
4. Chatfield C. The initial examination of data. J R Stat Soc A. 1985;148(3):214-53.
5. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal (updated June 2008). 2008.
6. Freeman JV, Walters SJ, Campbell MJ. How to display data. Oxford: BMJ Books; 2008.
7. Few S. Show me the numbers. California: Analytics Press; 2004.
8. Altman DG. Statistics and ethics in medical research. VI: presentation of results. Br Med J. 1980;281(6254):1542-4.
9. Hand DJ. Statistics and data mining: intersecting disciplines. ACM SIGKDD Explor Newslett. 1999;1(1):16-9.
10. Good P, Hardin J. Common mistakes in statistics (and how to avoid them). New Jersey: Wiley; 2003.
11. Harrell FE, Lee KL, Mark DB. Tutorial in biostatistics multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-87.
12. Royston P, Suaerbrei W. Multivariable model-building: a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables. Chichester: Wiley; 2008.
13. Little RJA, Rubin DB. Statistical analysis with missing data. 2nd ed. New York: Wiley; 2002.
14. Briggs A, Clark T, Wolstenholme J, Clarke P. Missing. presumed at random: cost-analysis of incomplete data. Health Econ. 2003;12(5):377-92.
15. Briggs AH, Weinstein MC, Fenwick EA, Karnon J, Sculpher MJ, Paltiel AD. Model parameter estimation and uncertainty analysis a report of the ISPOR-SMDM modeling good research practices task force working group-6. Med Decision Mak. 2012;32(5):722-32.
16. Campbell MJ. Statistics at square two: understanding modern statistical applications in medicine. Oxford: BMJ Books; 2006
17. Cooper NJ, Sutton AJ, Mugford M, Abrams KR. Use of Bayesian Markov Chain Monte Carlo methods to model cost-of-illness data. Med Decision Mak. 2003;23(1):38-53.
18. Tufte E. Improving data analysis in political science. World Politics. 1969;21(4):641-54.
19. Machin D, Campbell MJ, Walters SJ. Medical statistics. 4th ed. Chichester: Wiley; 2007.
20. Ara R, Brazier J. Predicting the short form-6D preference-based index using the eight mean short form-36 health dimension scores: estimating preference-based health-related utilities when patient level data are not available. Value Health. 2009;12(2):346-53.
21. Sullivan PW, Ghushchyan V. Preference-based EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006;26(4):410-20.
22. Sullivan PW, Slejko JF, Sculpher MJ, Ghushchyan V. Catalogue of EQ-5D scores for the United Kingdom. Med Decis Making. 2011;31(6):800-4.
23. Dobrez D, Cella D, Pickard AS, Lai JS, Nickolov A. Estimation of patient preference-based utility weights from the functional assessment of cancer therapy-general. Value Health. 2007;10(4):266-72.
24. Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford: Oxford University Press; 2006.
25. Stevenson M, Tappenden P, Squires H. Methods for handling uncertainty within pharmaceutical funding decisions. Int J Syst Sci 2012. Available from: http://www.tandfonline.com/doi/abs/10.1080/00207721.2012.723056?journalcode= tsys20#.ubqbazqn0cB
26. Strong M, Oakley JE, Chilcott J. Managing structural uncertainty in health economic decision models: a discrepancy approach. J R Stat Soc Ser C. 2012;61(1):25-45.
27. Husereau D, Drummond D, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. Pharmacoeconomics. 2013;31(5):361-7.